Application of red rice extract, red rice extract and preparation method of red rice extract
Through the extraction method of red rice extract aqueous diol solution, the problem of difficulty in exerting multiple functions at the same time in the prior art is solved, and the expression of heat shock proteins is promoted, DNA damage is repaired, sunburned cells are reduced, and cell aging is resisted. The effect of inhibiting inflammation has significantly improved the effects of sun protection and post-sun repair.
Patent Information
- Application Number
- CN202411238793.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art is difficult to simultaneously exert the effects of promoting heat shock protein expression, repairing DNA damage, reducing sunburned cells, resisting cell aging and inhibiting inflammation, and other functional activities of red rice extract have not been fully utilized.
By using red rice extract and using aqueous solution extraction method of diol, drugs or cosmetics have the effects of promoting heat shock protein expression, repairing DNA damage, reducing sunburned cells, resisting cell aging and inhibiting inflammation. The method includes extraction of red rice and diol aqueous solution, and the supernatant obtained by solid-liquid separation is red rice extract. By upregulating HSF1 gene expression and HSP70 gene expression, the content of 8-OHdG and CPD is reduced, and the expression of P53 gene is inhibited, and the expression of P53 gene is inhibited by upregulating HSF1 gene expression and HSP70 gene expression is reduced, and the expression of 8-OHdG and CPD is inhibited. and NF-kB activity.
Redmi extract significantly increased the expression rate of HSP70, reduced the number of sunburned cells, effectively repaired DNA damage, inhibited the expression of the inflammatory factor NF-kB, achieved a therapeutic effect comparable to dexamethasone, and significantly delayed cell aging. Phenomenon.
Smart Images

Figure CN119055730A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an application of a red rice extract, a red rice extract and a preparation method thereof. Background Art
[0002] Exposure to sunlight for a long time or at high intensity exposes the skin to many stresses, especially those caused by heat and UV radiation. All cells in humans or animals specifically respond to this type of stress by synthesizing heat shock proteins (HSPs), which constitute an important cellular protection system. HSPs are divided into 5 categories based on their molecular weight and sequence homology: HSP 110, HSP 90, HSP 70, HSP 60 and HSP 27. The first function of these proteins is heat resistance, so when keratinocytes are exposed to 40°C for 1 hour, the mRNA level and HSP synthesis increase. These proteins not only provide protection, but also provide the reproduction of functional proteins, the maintenance of cell function and the restoration of basic metabolic functions, while allowing the elimination of harmful free radicals. HSP 70s represent the most studied proteins, because they are mainly synthesized by eukaryotic cells. In this category there are two forms, one is the constitutive HSP 73 or 70, and the other is the inducible HSP 72. HSP 72 is induced by heat as well as by UV. However, this induction ability weakens with age. Whether before or after heat stress, the level of HSP72 expressed by fibroblasts in young people is higher than that in the elderly. Heat shock protein transcription factor 1 (HSF1) is a classic heat shock transcription factor, which is traditionally believed to activate the expression of molecular chaperone HSPs under various stress conditions such as heat shock to maintain intracellular protein homeostasis.
[0003] Deoxyribonucleic acid (DNA), an essential component of human cells, is constantly eroded or damaged by a variety of chemicals and agents, a process known as DNA damage. This damage can be caused by any internal or external factors in the body, and if the damaged DNA is not repaired, it may lead to mutations and serious genetic diseases or genetic instability. The free radical associated with oxidative-induced DNA damage is usually 8-hydroxy-2'-deoxyguanosine (8-OHdG). Reactive oxygen species (ROS) are constantly formed as byproducts of oxidative respiration and heavy metal-mediated Fenton reactions, causing DNA damage; macrophages and neutrophils at sites of inflammation and infection also produce reactive oxygen and nitrogen species, which attack DNA, resulting in adducts that impair base pairing and / or block DNA replication and transcription, base loss, or DNA single-strand breaks (SSBs). It is estimated that approximately 100-500 8-OHdG lesions are formed in human cells every day due to oxidative damage. In addition to endogenous sources, DNA can also be damaged by exogenous substances in the environment. These include physical genotoxic stresses, such as ultraviolet light, which induces various mutagenic and cytotoxic DNA damage, such as cyclobutane-pyrimidine dimers (CPDs). It is well known that ultraviolet radiation can also cause extrinsic skin aging by destroying the genetic material structure in keratinocytes and affecting the apoptotic signaling pathway, leading to cell damage and cell death. These apoptotic cells are called sunburn cells.
[0004] The NF-κB signaling pathway, or nuclear factor-κB, is a protein found in mature B cells and plasma cells that can specifically bind to enhancers contained in immunoglobulin light chains. NF-κB plays a key role in cellular immunity, inflammation, and cell survival, especially promoting the secretion of a variety of inflammatory factors. The development of NF-κB inhibitors is of great significance for studying its biological functions and developing anti-inflammatory and anti-cancer drugs.
[0005] The increased expression level of the P53 gene is the main cause of cell aging and various aging phenomena. If the expression level of the P53 gene is reduced, the cell will stop aging. Therefore, there are many studies in the prior art on how to effectively reduce the expression of the P53 gene.
[0006] Promoting the expression of heat shock proteins can repair heat damage, inhibiting 8-OHdG and CPD can repair DNA damage, inhibiting the expression of P53 gene can resist aging, and inhibiting NF-κB activity can inhibit or treat inflammation. These effects are particularly important in the fields of cosmetics, health care and medicine. The active substances reported so far are often only known to be able to exert one of these effects or some of the effects are not significant. If they can exert multiple effects at the same time or significantly improve one of the effects, it will be of progressive significance.
[0007] Red rice is one of the colored grains among whole grains, and it appears red because of the pigments deposited on its seed coat. The high content of proanthocyanidins in red rice extract makes it have excellent antioxidant activity, so it has been reported in the literature that it has the effect of reducing chronic diseases such as cancer and cardiovascular disease. The pharmaceutical uses or the use of preparing cosmetics reported in the prior art for red rice extract are all centered around its strong antioxidant activity, and it is still unknown whether it has other functional activities. Summary of the invention
[0008] In view of the above problems, the present invention provides the application of red rice extract and the preparation method of red rice extract. The red rice extract prepared by the present invention has the effects of inducing heat shock protein expression, repairing DNA damage, reducing sunburned cells, resisting cell aging and inhibiting inflammation, and can be used to prepare medicines, cosmetics and health products.
[0009] The present invention solves the above technical problems through the following technical solutions.
[0010] One aspect of the present invention provides an application of a red rice extract in the preparation of a medicine, cosmetic or health product having at least one or more effects of promoting heat shock protein expression, repairing DNA damage, reducing sunburned cells, resisting cell aging and inhibiting inflammation. The preparation method of the red rice extract comprises the following steps: extracting red rice with an aqueous solution of a diol and then subjecting the extract to solid-liquid separation to obtain a supernatant, which is the red rice extract.
[0011] In a specific embodiment of the present invention, the heat shock protein is a heat shock protein 70 family. Preferably, the red rice extract achieves the effect of repairing heat damage by upregulating the expression of HSF1 gene and HSP70 gene. Preferably, the heat shock protein is a heat shock protein in keratinocytes. Those skilled in the art know that by increasing the gene expression of HSP70, the skin heat sensation and collagen degradation caused by heat can be reduced.
[0012] In a specific embodiment of the present invention, the DNA damage is oxidative-induced DNA damage and / or UVB-induced DNA damage. Preferably, the red rice extract achieves the effect of repairing DNA damage by reducing the content of 8-hydroxydeoxyguanosine and / or the content of cyclobutane pyrimidine dimer in the skin epidermis.
[0013] In a specific embodiment of the present invention, the sunburned cells are apoptotic keratinocytes. Wherein, apoptosis refers to the phenomenon that the genetic material structure of the skin epidermis is destroyed after UVB irradiation, causing the keratinocytes in the skin epidermis to enter the death program. In the present invention, the application of the red rice extract in the skin epidermis can significantly reduce the number of sunburned cells and reduce the sunburn phenomenon of the skin compared to the control group without application.
[0014] In the present invention, the protection against cell aging is achieved by inhibiting the expression of P53 gene. In a specific embodiment of the present invention, the inhibition of P53 gene expression is to inhibit the overexpression of P53 gene caused by UVB irradiation of keratinocytes.
[0015] In the present invention, the inhibition of inflammation is preferably achieved by inhibiting the activity of NF-kB. In a specific embodiment of the present invention, the inhibition of inflammation is to inhibit the activation of NF-kB in the skin epidermis caused by UVB irradiation.
[0016] In the present invention, the drug preferably includes a drug for treating or inhibiting inflammation, and the inflammation includes inflammatory diseases caused by UVB irradiation. The inhibition rate of the red rice extract on NF-kB is comparable to that of dexamethasone. It is well known that dexamethasone has an excellent therapeutic effect on inflammation.
[0017] In the present invention, the cosmetics preferably include cosmetics with sun protection, after-sun repair, oil control and acne removal, anti-inflammatory and soothing or anti-aging effects.
[0018] In the present invention, the health care product is preferably a health care product with sun protection, after-sun repair or anti-aging effects.
[0019] The red rice extract of the present invention can promote the repair of DNA damage and the expression of heat shock proteins, and can enhance the effects of sun protection and post-sun repair.
[0020] In a specific embodiment of the present invention, the red rice refers to red rice bran. Those skilled in the art know that the red rice includes rice bran, germ and germ, wherein the rice bran includes pericarp, seed coat, endosperm and aleurone layer. Therefore, in a preferred embodiment of the present invention, the active ingredients in the red rice bran are directly extracted.
[0021] In a preferred embodiment of the present invention, the red rice bran is in powder form, and the D50 particle size of the red rice bran is 20-100 microns. The D50 particle size of the red rice bran is within this range, so that the polyphenol active substances can be effectively extracted by the solvent.
[0022] In a preferred embodiment of the present invention, the diol has 2-6 carbon atoms, preferably 3 or 4 carbon atoms, and may be propylene glycol and / or butylene glycol, specifically 1,3-butylene glycol.
[0023] In a specific embodiment of the present invention, the mass ratio of the red rice to the aqueous solution of the diol is 1:(4-19), preferably 1:5 or 1:6. If the mass ratio of the red rice to the aqueous solution of the diol is smaller, the concentration of the extracted sample solution will be low, and the energy consumption of the extraction will increase if more concentration is required. Therefore, in a specific embodiment of the present invention, the material-liquid ratio is selected to be 1:5, which takes into account both a higher extraction rate and lower energy consumption.
[0024] In a specific embodiment of the present invention, the mass concentration of the diol in the diol aqueous solution is 30-80%, preferably 50%, 60%, 70% or 75%, and the mass concentration refers to the percentage of the mass of the diol to the total mass of the diol aqueous solution.
[0025] In the present invention, the extraction may be the meaning commonly understood in the art, generally referring to immersing the plant to be extracted in a solvent. In a specific embodiment of the present invention, the extraction method is leaching, stirring extraction, reflux extraction or ultrasonic extraction, preferably stirring extraction. In a specific embodiment of the present invention, the rotation speed of the stirring extraction is 150-200rpm.
[0026] In a specific embodiment of the present invention, the extraction temperature is 35-80°C, preferably 40°C or 50°C.
[0027] In a specific embodiment of the present invention, the extraction time is 1.0-48.0 hours, preferably 8.0 hours, 10.0 hours, 12.0 hours or 14.0 hours. In a preferred embodiment of the present invention, the extraction time is 12.0 hours, under which the active ingredient can be fully extracted.
[0028] In a specific embodiment of the present invention, the solid-liquid separation is centrifugation and / or membrane filtration, wherein the membrane filtration uses a 0.22-8.00 μm filter membrane for filtration.
[0029] In a specific embodiment of the present invention, after obtaining the supernatant, filtration is generally performed in order to further fully remove the residual solids in the supernatant. The size of the filter membrane for filtration can be conventional in the art and can remove non-polyphenol particles without special limitation. It is generally 0.22-8.00 μm, preferably 0.50 μm.
[0030] Another aspect of the present invention provides a method for preparing a red rice extract, which comprises the following steps: extracting red rice with an alcohol aqueous solution and performing solid-liquid separation to obtain a supernatant, which is the red rice extract; the alcohol is 1,3-butanediol, the red rice bran is in powder form, and the D50 particle size of the red rice bran is 20-100 microns.
[0031] Another aspect of the present invention further provides a red rice extract, which is prepared by the above-mentioned preparation method of the red rice extract.
[0032] Positive and progressive effects: The red rice extract prepared by the present invention has the effects of repairing heat damage, repairing DNA damage, inhibiting inflammation and anti-aging, and has significant effects in all aspects:
[0033] (1) The red rice extract prepared by the present invention has the effect of repairing heat damage, can activate the expression of the thermoprotein production gene HSF1 at a safe concentration, and increase the expression of HSP70. The HSP70 expression rate is increased by 98%, which is a significant effect. It can effectively protect the skin from heat sensation and collagen degradation caused by heat.
[0034] (2) The red rice extract prepared by the present invention can protect DNA damage, reduce the reduction of DNA damage markers CPD and 8-OHdG caused by sunlight radiation, and thus effectively repair skin sunburn, tanning and aging caused by UVB irradiation.
[0035] (3) The red rice extract prepared by the present invention can reduce sunburn cells by more than 80%, and there is basically no sunburn phenomenon under UVB irradiation, which can play an effective sunscreen role.
[0036] (4) The red rice extract prepared by the present invention has an inhibition rate of up to 68.66% on P53 gene expression, which is twice that of vitamin E. It can more effectively delay sun aging and repair DNA damage caused by UVB irradiation.
[0037] (5) The red rice extract prepared by the present invention can effectively inhibit the expression of the inflammatory factor NF-kB, and can achieve an effect equivalent to that of dexamethasone in treating inflammation. It is pure plant source, safe and efficient.
[0038] The concept and technical effects of the present invention will be further described below in conjunction with the accompanying drawings to fully understand the purpose, features and effects of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 Standard curve of the absorbance of gallic acid working solution and the gallic acid concentration of each working solution during the total polyphenol content test.
[0040] Figure 2 This is a cell viability curve diagram of the red rice extract of Example 1 at different concentration gradients.
[0041] Figure 3 The morphological characterization pictures of cell viability at different concentrations of red rice extract in Example 1 are shown in FIG. Figure 3 A. Figure 3 B. Figure 3 C. Figure 3 D. Figure 3 E and Figure 3 F represents the morphological characterization pictures of cell viability of red rice extracts with concentrations of 1.25%, 0.625%, 0.3125%, 0.15625%, 0.078125% and the solvent control group, respectively.
[0042] Figure 4These are microscopic images of the tissue morphology of each group in the UVB-irradiated 3D epidermal skin model test.
[0043] Figure 5 This is a bar graph showing the results of sunburned cells in each group in the UVB irradiated 3D epidermal skin model test.
[0044] Figure 6 These are the 8-OHdG immunofluorescence images of each group in the UVB-irradiated 3D epidermal skin model test.
[0045] Figure 7 These are the NF-κB immunofluorescence images of each group in the UVB-irradiated 3D epidermal skin model test.
[0046] Figure 8 This is a bar graph of the relative integrated optical density values of 8-OHdG in each group in the UVB-irradiated 3D epidermal skin model test.
[0047] Fig. 9 This is a bar graph showing the relative integrated optical density values of NF-κB in each group in the UVB-irradiated 3D epidermal skin model test.
[0048] Fig.10 These are the immunohistochemistry images of DNA damage CPD in each group in the UVB-irradiated 3D epidermal skin model test.
[0049] Fig.11 This is a bar graph of the relative integrated optical density values of DNA damage CPD in each group in the UVB irradiated 3D epidermal skin model test.
[0050] Fig.12 This is a bar graph showing the HSF1 gene test results for each group in the keratinocyte test.
[0051] Fig.13 This is a bar graph showing the results of HSF70 gene detection in each group in the keratinocyte test.
[0052] Fig.14 This is a bar graph showing the P53 gene detection results for each group in the UVB irradiated keratinocyte test. DETAILED DESCRIPTION
[0053] In order to make the technical means, creative features, objectives and effects of the invention easier to understand, the invention is further described below with reference to specific diagrams. However, the invention is not limited to the following implementation cases.
[0054] The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be regarded as specifically disclosed in this article. In the present invention, a certain point value refers to a value including the point value itself and a value less than the point value. The present invention will be described in detail below by examples. In the following examples, unless otherwise specified, the various raw materials used can be obtained from commercial channels. In the present invention, the term "repair" covers the meanings of care, protection, recovery and restoration. For example, the repair of DNA damage can be understood as using it before DNA damage to achieve the effect of care and protection, and using it after DNA damage to achieve the effect of restoration and recovery.
[0055] The source of the red rice bran plant powder in the following examples is as follows: Yunnan Yingge Biotechnology Co., Ltd.
[0056] In the following examples, the % in the 70% alcohol aqueous solution refers to the percentage of the mass of the corresponding alcohol to the total mass of the alcohol aqueous solution.
[0057] Example 1
[0058] Take a clean beaker, weigh 10g of the above red rice bran plant powder, grind the red rice bran plant powder to a D50 particle size of 20-100 microns. Put the ground red rice bran plant powder in a beaker, add 50g of 1,3-butanediol in a 70% alcohol aqueous solution in the beaker, seal the beaker, stir and extract at 40°C for 12.0 hours, stirring at a speed of 150-200rpm, centrifuge to separate the solid and liquid, and filter the supernatant through a 0.50μm filter membrane to obtain a plant stock solution, which is the red rice bran extract.
[0059] Effect Example 1 Detection of total polyphenol content
[0060] Test method: GBT 8313-2008 Method 2: Detection of tea polyphenols content in tea leaves
[0061] Prepare 10% Folin-Ciocalteu reagent, 7.5% Na2CO3, standard solution: gallic acid is prepared into 0.4455 mg / mL solution with water, and then diluted into samples with concentration gradient of 0.01-0.2 mg / mL. According to the absorbance of gallic acid working solution and the gallic acid concentration of each working solution, the standard curve is as follows: Figure 1 shown.
[0062] Determination steps: Take 100 μL of the plant stock solution obtained in Example 1, add 500 μL of 10% Folin-Ciocalteu reagent, mix, let stand for 5 min-8 min, add 400 μL of 7.5% Na2CO3, mix, and keep at room temperature for 60 min. Take 100 μL and use a spectrophotometer to measure the OD value of the sample at 765 nm. Substitute it into the standard curve equation to obtain the total polyphenol content in the sample solution to be tested. The concentration of polyphenols in the plant stock solution in Example 1 is calculated to be 3.036 mg / mL.
[0063] Effect Example 2
[0064] 1. Test basis
[0065] According to the 3D epidermal skin model based on UVB irradiation The tests were carried out using the following methods: tissue morphology, 8-hydroxydeoxyguanosine (8-OHdG), nuclear transcription factor (NF-κB), and DNA damage cyclobutane pyrimidine dimer (CPD) content detection method, HSF1 and HSP70 gene expression detection method based on keratinocytes, and P53 gene expression detection method based on UVB irradiated keratinocytes.
[0066] 2. Test Purpose
[0067] This test is divided into four parts: the first part is based on keratinocytes, and cytotoxicity testing is carried out to determine the concentration of the sample on keratinocytes; the second part uses UVB to irradiate the 3D epidermal skin model By detecting changes in tissue morphology, 8-OHdG, NF-κB, and DNA damage cyclobutane pyrimidine dimer (CPD) content, the test samples' effects on repairing DNA damage and inhibiting inflammation were evaluated; the third part was based on keratinocytes, detecting changes in HSF1 and HSP70 gene expression levels, and evaluating the test samples' effects on repairing thermal damage; the fourth part used UVB to irradiate keratinocytes to detect changes in P53 gene expression levels.
[0068] 3. Test materials
[0069] The main reagents are shown in Table 1 below:
[0070] Reagents factory KcGrowth culture medium Guangdong Boxi Biotechnology EpiGrowth Medium Guangdong Boxi Biotechnology PBS Solebao MTT Sigma DMSO Sigma Vitamin E VE, Sigma / China Inspection Institute WY14643 Sigma Dexamethasone China Inspection and Quarantine Institute Paraformaldehyde Biosharp DNA damage CPD antibodies CosMo Bio Co.LTD. 8-OHdG Antibody Abcam NF-κB Antibody Abcam Xylene Sinopharm Hematoxylin Blue Sky Erythrocyte Blue Sky RNAiso Plus Aikerui Biotechnology Reverse transcription kit Aikerui Biotechnology Fluorescent dyes Aikerui Biotechnology
[0071] Main equipment: CO2 incubator (Thermo, 150I), clean bench (Sujing Antai, SW-CJ-1F), upright microscope (Olympus, BX53), UVB irradiator (Philips), ordinary PCR instrument (Bioray), fluorescence quantitative PCR instrument (BioRad, CFX-96), fluorescence microscope (Olympus, BX43), microplate reader (BioTek, Epoch), inverted microscope (Olympus, CKX53).
[0072] The sample to be tested is: the plant stock solution prepared in Example 1, hereinafter referred to as "active substance 1".
[0073] The model used in this test is a 3D epidermal skin model Batch number: MS240604, provided by Guangdong Boxi Biotechnology Co., Ltd.
[0074] 4. Cytotoxicity test
[0075] 4.1 Cell viability test method
[0076] 1) Cell inoculation: After the cells are revived, when the plating rate reaches about 60%, the cells are inoculated into a 96-well plate and incubated overnight in a CO2 incubator (37°C, 5% CO2).
[0077] 2) Experimental grouping: The experiment set up a zero adjustment group, a solvent control group, a positive control group and a sample group. In the sample group, each sample was set with 8 concentration gradients, and 3 replicate wells were set under each concentration gradient.
[0078] 3) Solution preparation: Prepare sample working solutions of different concentrations according to the test concentration setting table (Table 2, concentration range is 0.078125-10% v / v).
[0079] 4) Administration: Administration was performed when the cell plating rate in the 96-well plate reached 50% to 60%. 200 μL of culture medium was added to each well of the solvent control group; 200 μL of culture medium containing 10% DMSO was added to each well of the positive control group; 200 μL of culture medium containing the corresponding concentration of the sample to be tested was added to each well of the sample group; there was no cell inoculation in the zero adjustment group, and only 200 μL of cell culture medium was added. After administration, the 96-well plate was placed in a CO2 incubator (37°C, 5% CO2) for 24 hours.
[0080] 5) Detection: After the cells were incubated for 24 h, the supernatant was discarded, and MTT working solution (0.5 mg / mL) was added. The cells were incubated at 37° C. in the dark for 4 h. After the incubation, the supernatant was discarded, 150 μL DMSO was added to each well, and the OD value was read at 490 nm.
[0081] 6) Calculation of relative cell viability: relative cell viability (%) = (OD of sample well - OD of apoptosis well) / (OD of solvent control well - OD of apoptosis well) x 100%.
[0082] Table 2 Test concentration setting table
[0083]
[0084] Note: Concentration gradient (%, v / v) refers to the volume of the plant stock solution prepared in Example 1 / the volume of the culture solution containing 10% DMSO.
[0085] 4.2 Cell morphology test method
[0086] 1) Cell inoculation: After the cells are revived, when the plating rate reaches about 60%, the cells are inoculated into a 24-well plate and incubated overnight in a CO2 incubator (37°C, 5% CO2).
[0087] 2) Test grouping: The experiment set up a solvent control group and a sample group. In the sample group, 5 concentration gradients were set for each sample.
[0088] 3) Administration: Administration was performed when the cell plating rate in the 24-well plate reached 50% to 60%. 1 mL of culture medium was added to each well of the solvent control group; 1 mL of culture medium containing the sample of the corresponding concentration was added to each well of the sample group. After administration, the 24-well plate was placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours.
[0089] 4) Photography: After incubation, discard the supernatant and take photos under an inverted microscope.
[0090] 4.3 Test Results
[0091] The test results of cell viability are shown in Table 3 below, and a cell viability curve of active substance 1 is also plotted. Figure 2 shown.
[0092] Table 3
[0093]
[0094] The results of the cell morphology test are as follows Figure 3 As shown. Figure 3 It can be clearly seen that at a concentration of 0.625%, a small amount of cell viability was lost, but at 0.3125%, the cell morphology was basically intact.
[0095] Therefore, based on the MTT and morphological results, it was considered that Active 1 did not show significant cytotoxicity on keratinocytes within the concentration range of 0.3125% (v / v).
[0096] 5. 3D epidermal skin model based on UVB irradiation Test
[0097] 5.1 Test Method
[0098] 5.1.1 Test Grouping
[0099] The test groups are shown in Tables 4 and 5 below.
[0100] Table 4 Test Group-1
[0101]
[0102] Note: PC1 is the positive control for tissue morphology detection; PC2 is the positive control for 8-OHdG detection; PC3 is the positive control for NF-κB detection.
[0103] Table 5 Test Group-2
[0104]
[0105]
[0106] 5.1.2 Model irradiation and drug administration
[0107] 1) According to the test group, transfer the model to a 6-well plate (add 0.9 mL EpiGrowth culture medium in advance) and mark the test group number on the 6-well plate.
[0108] 2) Irradiation: According to the test groups, except for the blank control group, the other groups were irradiated with UVB, and the irradiation dose was 600mJ / cm 2 , irradiation time is 2min29s.
[0109] 3) Administration: After irradiation, the corresponding working solution was added to the PC group liquid, and the sample group evenly distributed the sample working solution on the model surface. The administration volume was 25 μL of EpiGrowth culture solution containing 1% volume concentration of active ingredient 1.
[0110] 4) Model incubation: After administration, the cells were placed in a CO2 incubator (37°C, 5% CO2) and incubated for 24 h.
[0111] 5) Cleaning: After the incubation, clean the remaining test substance with sterile PBS solution and wipe off the residual liquid with a sterile cotton swab.
[0112] 5.1.3 Tissue morphology test
[0113] The model used for testing was fixed with 4% paraformaldehyde for 24 hours, and then stained with H&E. The collected pictures were observed under a microscope. Figure 4As shown, the circled cells are sunburn cells.
[0114] 5.1.4 Immunofluorescence test
[0115] The model for testing was fixed with 4% paraformaldehyde for 24 hours, and then immunofluorescence detection was performed. The images were taken under a microscope and analyzed. Figure 6 NF-κB immunofluorescence images are shown in Figure 7 shown.
[0116] 5.1.5 Immunohistochemistry test
[0117] The model used for testing was fixed with 4% paraformaldehyde for 24 hours, and then immunohistochemical detection was performed. The collected pictures were taken under a microscope. Fig.10 shown.
[0118] 5.1.6 Calculation of inhibition rate
[0119] Inhibition rate (%) = [(negative control group - sample group) / (negative control group - blank control)] x 100%.
[0120] 5.1.7 Statistical analysis of results
[0121] GraphPad Prism was used for graphing, and the results were expressed as Mean ± SD. The t-test was used for statistical analysis between the groups. All statistical analyses were two-tailed. P < 0.05 was considered to be significantly different, and P < 0.01 was considered to be extremely significantly different.
[0122] 5.2 Test Results
[0123] according to Figure 4 The number of sunburned cells shown is shown in Table 6 and Figure 5 As shown. The experimental results show that compared with the BC group, the number of sunburned cells in the NC group increased significantly, indicating that the stimulation conditions of this test were effective; compared with the NC group, the number of sunburned cells in the PC1 group decreased significantly, indicating that the positive control of this test was effective; compared with the NC group, the number of sunburned cells in the sample active substance -1% decreased significantly, and the inhibition rate was 83.33%. Among them, WY14643 is a PPAR activator, and the PPAR-related signaling pathway can regulate the orderly proliferation of cells, thereby enhancing the barrier function of all systems related to damage.
[0124] Table 6 Histological morphology analysis results
[0125] Group Sunburn cells (number) SD P-Value Inhibition rate (vs NC) BC 0 0.58 / / NC 6 1.53 0.005## / PC1 1 0.58 0.001** 83.33% Active matter - 1% 1 0.58 0.002** 83.33%
[0126] Note: When the t-test method was used for statistical analysis, compared with the BC group, the significance was indicated by #, P-value < 0.05 was indicated by #, and P-value < 0.01 was indicated by ##; compared with the NC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.
[0127] According to Figure 6 The 8-OHdG immunofluorescence images shown in the figure are shown in Table 7, and the corresponding 8-OHdG relative integrated optical density value bar graph is shown in Table 7. Figure 8 The experimental data showed that compared with the BC group, the 8-OHdG content of the NC group increased significantly, indicating that the stimulation conditions of this test were effective; compared with the NC group, the 8-OHdG content of the PC2 group decreased significantly, indicating that the positive control of this test was effective; compared with the NC group, the 8-OHdG content of the active substance 1-1% decreased significantly, and the inhibition rate was 82.22%.
[0128] Table 7 8-OHdG immunofluorescence analysis results
[0129] Group Relative IOD average SD P-value Inhibition rate (vs NC) BC 1.00 0.11 / / NC 1.90 0.10 0.001## / PC2 1.26 0.07 0.001** 71.11% Active matter - 1% 1.16 0.13 0.001** 82.22%
[0130] Note: The integrated optical density (IOD) reflects the content of 8-OHdG. When the t-test method is used for statistical analysis, compared with the BC group, the significance is indicated by #, P-value < 0.05 is indicated by #, and P-value < 0.01 is indicated by ##; compared with the NC group, the significance is indicated by *, P-value < 0.05 is indicated by *, and P-value < 0.01 is indicated by **.
[0131] according to Figure 7 The NF-κB immunofluorescence images shown in the figure, the statistical results of the NF-κB inhibition rate are shown in Table 8, and the corresponding NF-κB relative integrated optical density value bar graph is shown in Fig. 9 The experimental data showed that compared with the BC group, the NF-κB content of the NC group increased significantly, indicating that the stimulation conditions of this test were effective; compared with the NC group, the NF-κB content of the PC3 group decreased significantly, indicating that the positive control of this test was effective; compared with the NC group, the NF-κB content of the sample Taremi Plus-1% decreased significantly, with an inhibition rate of 50.72%.
[0132] Table 8 NF-κB immunofluorescence analysis results
[0133]
[0134]
[0135] Note: The integrated optical density (IOD) reflects the content of NF-κB. When the t-test method was used for statistical analysis, compared with the BC group, the significance was indicated by #, P-value < 0.05 was indicated by #, and P-value < 0.01 was indicated by ##; compared with the NC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.
[0136] according to Fig.10 The DNA damage CPD immunohistochemistry images shown in the figure are shown in Table 9. The statistical results of the CPD content in each group are shown in Table 9. The corresponding bar chart statistics are shown in Fig.11 As shown. The experimental results show that: compared with the BC group, the DNA damage CPD content of the NC (24h) group increased significantly, indicating that the stimulation conditions of this test are effective. Compared with the NC (24h) group, the DNA damage CPD content of the PC group decreased significantly, indicating that the positive control of this test is effective; compared with the NC (24h) group, the DNA damage CPD content of the sample active matter 1-1% decreased significantly, and the inhibition rate was 33.81%. The difference in the DNA damage CPD content of the sample active matter 1-1% is 3.89 times that of the DNA damage CPD content of the NC group.
[0137] Table 9 Results of CPD immunohistochemistry analysis
[0138]
[0139] Note: The integrated optical density (IOD) reflects the content of DNA damage CPD. When the t-test method is used for statistical analysis, compared with the BC group, the significance is indicated by #, P-value < 0.05 is indicated by #, and P-value < 0.01 is indicated by ##; compared with the NC (24h) group, the significance is indicated by *, P-value < 0.05 is indicated by *, and P-value < 0.01 is indicated by **.
[0140] 6. Keratinocyte-based tests
[0141] 6.1 Test Method
[0142] 1) Cell inoculation: After the cells are revived, when the plating rate reaches about 60%, the cells are inoculated into a 6-well plate and incubated overnight in a CO2 incubator (37°C, 5% CO2).
[0143] 2) Liquid preparation: Prepare the working solution of the test substance according to the test groups in Table 10.
[0144] Table 10 Test Grouping
[0145]
[0146]
[0147] 3) Administration: According to the test grouping, when the cell plating rate in the 6-well plate reaches 40% to 60%, group administration is carried out, and 3 replicate wells are set up for each group. 2 mL of culture medium is added to each well of the blank control group, 2 mL of culture medium containing VE is added to each well of the positive control group, and 2 mL of culture medium containing the corresponding sample to be tested is added to each well of the sample group. After the administration is completed, the 6-well plate is placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours.
[0148] 4) Collect cells: After culturing for 24 hours, wash twice with 1 mL / well PBS, add 1 mL RNAiso Plus to each well, pipette and lyse the cells, and collect samples.
[0149] 5) Gene expression detection: RNA was extracted and reverse transcribed into cDNA, and then fluorescence quantitative PCR was performed. -△△CT Method to calculate the results.
[0150] 6) Calculation of up-regulation rate: Up-regulation rate (%) = [(sample group - blank control group) / blank control group] x 100%.
[0151] 7) Statistical analysis of results: GraphPad Prism was used for graphing, and the results were expressed as Mean ± SD. The t-test was used for statistical analysis between the groups. All statistical analyses were two-tailed. P < 0.05 was considered to be significantly different, and P < 0.01 was considered to be extremely significantly different.
[0152] 6.1 Test Results
[0153] The test results of HSF1 detection index based on keratinocyte test are shown in Table 11 and Fig.12 The experimental results show that compared with the BC group, the expression of HSF1 gene in the PC group was significantly upregulated, indicating that the positive control of this test is effective. Compared with the BC group, the expression of HSF1 gene in the sample active substance 1-0.3125% was significantly upregulated, with an upregulation rate of 43.00%.
[0154] Table 11 HSF1 test results
[0155] Group Mean SD P-value Upward adjustment rate (vs BC) BC 1.00 0.05 / / PC 2.21 0.19 0.000** 121.00% Active matter 1-0.3125% 1.43 0.13 0.005** 43.00%
[0156] Note: Use 2 -△△CT Methods The results were calculated and the mRNA amplification fold of the BC group was normalized when the t-test method was used for statistical analysis. Compared with the BC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.
[0157] The test results of HSP70 detection index based on keratinocyte test are shown in Table 12 and Fig.13 The experimental results show that compared with the BC group, the expression of HSP70 gene in the PC group was significantly upregulated, indicating that the positive control of this test is effective. Compared with the BC group, the expression of HSP70 gene in the sample active substance 1-0.3125% was significantly upregulated, with an upregulation rate of 98.00%.
[0158] Table 12 HSP70 test results
[0159]
[0160]
[0161] Note: Use 2 -△△CT Methods The results were calculated and the mRNA amplification fold of the BC group was normalized when the t-test method was used for statistical analysis. Compared with the BC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.
[0162] 7. Test based on UVB irradiation of keratinocytes
[0163] 7.1 Test Method
[0164] 1) Cell inoculation: After the cells are revived, when the plating rate reaches about 60%, the cells are inoculated into a 6-well plate and incubated overnight in a CO2 incubator (37°C, 5% CO2).
[0165] 2) Solution preparation: Prepare the working solution of the test substance according to the test groups in Table 13.
[0166] Table 13 Test Grouping
[0167]
[0168] 3) Administration: According to the test grouping, when the cell plating rate in the 6-well plate reaches 30% to 50%, group administration is carried out, and 3 replicate wells are set up for each group. 2 mL of culture medium is added to each well of the blank control group and the negative control group, 2 mL of culture medium containing VE is added to each well of the positive control group, and 2 mL of culture medium containing the corresponding sample to be tested is added to each well of the sample group. After the administration is completed, the 6-well plate is placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours.
[0169] 4) UVB irradiation: According to the test groups, except for the blank control group, the rest of the groups were irradiated with UVB, and the irradiation dose was 300mJ / cm 2 After irradiation, the cells were placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours.
[0170] 5) Collect cells: After culturing for 24 hours, wash twice with 1 mL / well PBS, add 1 mL RNAiso Plus to each well, pipette and lyse the cells, and collect samples.
[0171] 6) Gene expression detection: RNA was extracted and reverse transcribed into cDNA, and then fluorescence quantitative PCR was performed. -△△CT Method to calculate the results.
[0172] 7) Calculation of down-regulation rate: Down-regulation rate (%) = [(negative control - sample group) / negative control group] * 100%
[0173] 8) Statistical analysis of results: GraphPad Prism was used for graphing, and the results were expressed as Mean ± SD. The t-test was used for statistical analysis between the groups. All statistical analyses were two-tailed. P < 0.05 was considered to be significantly different, and P < 0.01 was considered to be extremely significantly different.
[0174] 7.2 Test Results
[0175] The test results based on UVB irradiation of keratinocytes are shown in Table 14 and Fig.14 The experimental results showed that compared with the BC group, the P53 gene expression in the NC group was significantly upregulated, indicating that the stimulation conditions of this test were effective; compared with the NC group, the P53 gene expression in the PC group was significantly downregulated, indicating that the positive control of this test was effective; compared with the NC group, the P53 gene expression in the sample active substance 1-0.3125% was significantly downregulated, with a downregulation rate of 68.66%.
[0176] Table 14 Summary of P53 gene test results
[0177] Group Mean SD P-value Downward adjustment rate BC 1.00 0.01 / / NC 1.34 0.10 0.004## / PC(VE) 0.93 0.11 0.008** 30.60% Active matter 1-0.3125% 0.42 0.05 0.000** 68.66%
[0178] Note: Use 2 -△△CT Methods The results were calculated and the mRNA amplification times of the BC group were normalized when the t-test method was used for statistical analysis. Compared with the BC group, the significance was indicated by #, P-value < 0.05 was indicated by #, and P-value < 0.01 was indicated by ##; compared with the NC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.
[0179] In summary, based on UVB irradiation 3D epidermal skin model Compared with the control group, at a concentration of 1% (v / v), the number of sunburned cells in sample active substance 1 was significantly decreased, with an inhibition rate of 83.33%; the contents of 8-OHdG, NF-κB, and DNA damage CPD were all significantly decreased, with inhibition rates of 82.22%, 50.72%, and 33.81%, respectively, indicating that the red rice extract of the present invention, at this concentration, reduces the contents of 8-OHdG and CPD and can repair DNA damage, inhibits the NF-κB factor and can inhibit inflammation.
[0180] Based on UVB irradiation of keratinocytes, compared with the control group, the expression of P53 gene in sample active substance 1 at a concentration of 0.3125% (v / v) was significantly downregulated, with a downregulation rate of up to 68.66%, indicating that the red rice extract of the present invention can inhibit the expression of P53 gene, thereby being able to more significantly delay aging.
[0181] Based on keratinocytes, compared with the control group, the sample active ingredient 1 at a concentration of 0.3125% (v / v), the expression levels of HSF1 and HSP70 genes were significantly upregulated, with the upregulation rates being 43.00% and 98.00%, respectively. It can effectively maintain intracellular protein homeostasis under heat stress conditions and relieve the stress on the skin caused by heat and ultraviolet radiation.
[0182] The preferred specific embodiments of the present invention are described in detail above. It should be understood that ordinary technicians in the field can make many modifications and changes based on the concept of the present invention without creative work. Therefore, all technical solutions that can be obtained by technicians in the technical field based on the concept of the present invention through logical analysis, reasoning or limited experiments on the basis of the prior art should be within the scope of protection determined by the claims.
Claims
1. A method for preparing a red rice extract for use in preparing a medicine, cosmetic or health product having at least one or more of the following effects: promoting heat shock protein expression, repairing DNA damage, reducing sunburned cells, resisting cell aging and inhibiting inflammation. The method for preparing the red rice extract comprises the following steps: The red rice is extracted with a diol aqueous solution and then the supernatant obtained by solid-liquid separation is the red rice extract.
2. The use according to claim 1, characterized in that The promoting the expression of heat shock proteins is up-regulating the expression of HSF1 gene and / or up-regulating the expression of HSP70 gene; And / or, the heat shock protein is a heat shock protein in keratinocytes.
3. The use according to claim 1, characterized in that The DNA damage is DNA damage induced by oxidation and / or DNA damage caused by UVB irradiation; And / or, the repairing of DNA damage is to reduce the content of 8-hydroxydeoxyguanosine and / or the content of cyclobutane pyrimidine dimer in the skin epidermis; And / or, the sunburned cells are apoptotic keratinocytes; wherein the apoptotic keratinocytes are produced by UVB irradiation of the skin epidermis.
4. The use according to claim 1, characterized in that The resisting of cell aging is to inhibit the expression of P53 gene; Wherein, the inhibition of P53 gene expression is to inhibit the overexpression of P53 gene caused by UVB irradiation of keratinocytes.
5. The use according to claim 1, characterized in that The inhibition of inflammation is inhibition of NF-kB activity; Wherein, the inhibition of NF-kB is to inhibit the activation of NF-kB in the skin epidermis caused by UVB irradiation.
6. The use according to claim 1, characterized in that The drug is a drug for treating or inhibiting inflammation; And / or, the cosmetics are cosmetics with sun protection, after-sun repair, oil control and acne removal, anti-inflammatory and soothing or anti-aging effects; And / or, the health care product is a health care product with sun protection, after-sun repair or anti-aging effects.
7. The use according to claim 1, characterized in that The red rice is red rice bran; The red rice bran is in powder form, and the D50 particle size of the red rice bran is 20-100 microns.
8. The use according to any one of claims 1 to 7, characterized in that The diol is 1,3-butanediol.
9. The use according to any one of claims 1 to 7, characterized in that: The mass ratio of the red rice to the aqueous solution of the diol is 1:(4-19); And / or, the mass concentration of the glycol in the glycol aqueous solution is 30-80%.
10. The use according to claim 9, characterized in that The mass ratio of the red rice to the aqueous solution of the diol is 1:5 or 1:6; And / or, the mass concentration of the diol in the diol aqueous solution is 65%, 70% or 75%.
11. The use according to any one of claims 1 to 7, characterized in that: The extraction temperature is 35-80°C; And / or, the extraction time is 1.0-48.0 hours; And / or, the extraction method is leaching extraction, stirring extraction, reflux extraction or ultrasonic extraction.
12. The use according to claim 11, characterized in that The extraction temperature is 40°C or 50°C; And / or, the extraction time is 10.0 hours, 12.0 hours or 14.0 hours; And / or, when the extraction is performed by stirring extraction, the stirring speed is 150-200 rpm.
13. The use according to any one of claims 1 to 7, characterized in that: The solid-liquid separation is centrifugation; After the solid-liquid separation, the method further comprises the step of filtering the supernatant.
14. A method for preparing a red rice extract, characterized in that: It includes the following steps: The supernatant obtained by extracting red rice bran with an alcohol aqueous solution and then separating the red rice bran into solid and liquid is the red rice extract; the alcohol is 1,3-butanediol, the red rice bran is in powder form, and the D50 particle size of the red rice bran is 20-100 microns.
15. A red rice extract, characterized in that The red rice extract is prepared by the preparation method according to claim 14.
Citation Information
Cited By
Application of procyanidine B2 or red rice extract in treatment of skin light injury
CN121534041A
